Deadline: February 3, 2027$1.5M

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. Offered by National Institutes of Health; awards $1.5M; applications due February 3, 2027.

Key Facts

Funder
National Institutes of Health
Award amount
$1.5M
Deadline
February 3, 2027
Geography
United States
Categories
Healthcare, Research
Status
Open

About This Grant

The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite.Applicants applying for funding under this NOFO should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB)...

Full requirements and application instructions: official listing.

Similar Open Grants

Deadlines Move. Your Search Shouldn't Start Over.

Get matched to open grants by eligibility and track every deadline in one workspace.